{"transactions":[{"id":706443,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-18T01:55:27.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":4406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (\"RSU\") will be settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."}],"balance_after":31406,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4406},"source":{"system":"sec-edgar","filing":"0001104659-26-084775","document":"tm2620763-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926084775/tm2620763-2_4seq1.xml","form_type":"4"}},{"id":717184,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-02T20:30:31.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 30, 2026 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service."}],"balance_after":32000,"derivative":{"exercise_price":3.66,"expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001193125-26-294699","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1617541/000119312526294699/ownership.xml","form_type":"4"}},{"id":742671,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-10T20:15:43.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award will fully vest upon the earlier of (a) the Issuer's next annual stockholder meeting, or (b) the one-year anniversary of the grant date, such to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":38000,"derivative":{"exercise_price":3.94,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001617541-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1617541/000161754126000005/primarydocument.xml","form_type":"4"}},{"id":749225,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:12:26.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":4882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."}],"balance_after":27000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4882},"source":{"system":"sec-edgar","filing":"0001104659-26-070524","document":"tm2616870-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926070524/tm2616870-5_4seq1.xml","form_type":"4"}},{"id":749224,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-04T20:12:26.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":4882,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the Issuer at one share per RSU."}],"balance_after":7387,"source":{"system":"sec-edgar","filing":"0001104659-26-070524","document":"tm2616870-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926070524/tm2616870-5_4seq1.xml","form_type":"4"}},{"id":766050,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-22T20:05:13.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) May 20, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":67000,"derivative":{"exercise_price":0.9946,"expiration_date":"2036-05-20","underlying":"Voting Common Stock","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001193125-26-236844","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000119312526236844/ownership.xml","form_type":"4"}},{"id":881415,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-02-26T01:48:43.000Z","date":"2026-02-23","kind":"grant","planned":false,"acquired":true,"shares":3984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (\"RSU\") will be settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU will fully vest on February 23, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU will fully vest on February 23, 2027."}],"balance_after":31882,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3984},"source":{"system":"sec-edgar","filing":"0001104659-26-019923","document":"tm267115-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926019923/tm267115-3_4seq1.xml","form_type":"4"}},{"id":950196,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-01-05T23:00:58.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":false,"shares":1808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 19, 2024, the Reporting Person was granted 8,207 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024. Outstanding RSUs were subsequently adjusted as described in footnote 6 below."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 19, 2024, the Reporting Person was granted 8,207 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024. Outstanding RSUs were subsequently adjusted as described in footnote 6 below."}],"balance_after":27898,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1808},"source":{"system":"sec-edgar","filing":"0001104659-26-000779","document":"tm261751-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926000779/tm261751-2_4seq1.xml","form_type":"4"}},{"id":950195,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-01-05T23:00:58.000Z","date":"2026-01-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1480,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person entered into an agreement with the Issuer pursuant to which the Reporting Person forfeited the right to receive 1,480 RSUs that would otherwise have vested in exchange for a payment from the Issuer to facilitate the Reporting Person's ability to satisfy certain tax obligations related to the RSUs scheduled to vest."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The number of RSUs forfeited is based on a percentage."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 19, 2024, the Reporting Person was granted 8,207 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024. Outstanding RSUs were subsequently adjusted as described in footnote 6 below."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 19, 2024, the Reporting Person was granted 8,207 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024. Outstanding RSUs were subsequently adjusted as described in footnote 6 below."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Reflects that the Reporting Person received 5,238 additional RSUs resulting from the adjustment of the RSUs held by the Reporting Person immediately prior to the separation of Par Health, Inc. (\"Par Health\") from the Issuer on November 10, 2025, pursuant to the terms of the Employee Matters Agreement by and between the Issuer and Par Health."}],"balance_after":29706,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1480},"source":{"system":"sec-edgar","filing":"0001104659-26-000779","document":"tm261751-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926000779/tm261751-2_4seq1.xml","form_type":"4"}},{"id":950194,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-05T23:00:58.000Z","date":"2026-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":513,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The number of ordinary shares withheld to satisfy tax withholding obligations arising out the vesting of RSUs is based on a percentage and did not take into account any market value as the Issuer's ordinary shares are not listed or quoted on a recognized trading market."}],"balance_after":2505,"source":{"system":"sec-edgar","filing":"0001104659-26-000779","document":"tm261751-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926000779/tm261751-2_4seq1.xml","form_type":"4"}},{"id":950193,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-05T23:00:58.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":true,"shares":1808,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the Issuer at one share per RSU."}],"balance_after":3018,"source":{"system":"sec-edgar","filing":"0001104659-26-000779","document":"tm261751-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926000779/tm261751-2_4seq1.xml","form_type":"4"}},{"id":1015721,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-10-20T20:16:21.000Z","date":"2025-10-17","kind":"grant","planned":false,"acquired":true,"shares":76000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award vests over a three year period equally one-thirty-sixth per month, subject to Reporting Person's continued service to the Company on each vesting date."}],"balance_after":76000,"derivative":{"exercise_price":1.19,"expiration_date":"2035-10-16","underlying":"Common Stock","underlying_shares":76000},"source":{"system":"sec-edgar","filing":"0001617541-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1617541/000161754125000005/primarydocument.xml","form_type":"4"}},{"id":1063539,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-08-19T01:03:58.000Z","date":"2025-08-14","kind":"grant","planned":false,"acquired":true,"shares":4062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (\"RSU\") will be settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."}],"balance_after":25948,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4062},"source":{"system":"sec-edgar","filing":"0001104659-25-079943","document":"tm2523680-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925079943/tm2523680-3_4seq1.xml","form_type":"4"}},{"id":1076028,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-08-05T00:50:46.000Z","date":"2025-07-31","kind":"grant","planned":false,"acquired":true,"shares":16414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 31, 2025, pursuant to the Transaction Agreement, dated as of March 13, 2025 (as amended, the \"Transaction Agreement\"), by and among Mallinckrodt plc (the \"Issuer\"), Endo, Inc. (\"Endo\") and Salvare Merger Sub LLC, the Issuer's wholly owned subsidiary (\"Merger Sub\"), the Merger Sub merged with and into Endo (the \"Business Combination\"), with Endo surviving the Business Combination as a wholly owned subsidiary of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon consummation of the Business Combination, each performance unit (\"PSU\") held by the reporting person automatically converted into a restricted unit (\"RSU\"). Each RSU will fully vest on December 25, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon consummation of the Business Combination, each performance unit (\"PSU\") held by the reporting person automatically converted into a restricted unit (\"RSU\"). Each RSU will fully vest on December 25, 2026."}],"balance_after":21886,"derivative":{"underlying":"Ordinary Shares","underlying_shares":16414},"source":{"system":"sec-edgar","filing":"0001104659-25-073790","document":"tm2522414-13_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925073790/tm2522414-13_4seq1.xml","form_type":"4"}},{"id":1095329,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:26:55.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 30, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":67000,"derivative":{"exercise_price":1.45,"expiration_date":"2035-06-30","underlying":"Voting Common Stock","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0000950170-25-093021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017025093021/ownership.xml","form_type":"4"}},{"id":1098965,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-30T20:15:16.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 26, 2025 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service."}],"balance_after":36000,"derivative":{"exercise_price":7.38,"expiration_date":"2035-06-25","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0000950170-25-091583","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1617541/000095017025091583/ownership.xml","form_type":"4"}},{"id":1318287,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-02T22:00:57.000Z","date":"2025-01-01","kind":"exercise","planned":false,"acquired":false,"shares":1504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 19, 2024, the reporting person was granted 8,207 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 19, 2024, the reporting person was granted 8,207 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024."}],"balance_after":5472,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1504},"source":{"system":"sec-edgar","filing":"0001104659-25-000367","document":"tm2432211-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925000367/tm2432211-2_4seq1.xml","form_type":"4"}},{"id":1318286,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-02T22:00:57.000Z","date":"2025-01-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1231,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The reporting person entered into an agreement with the issuer pursuant to which the reporting person forfeited the right to receive 1,231 RSUs that would otherwise have vested in exchange for a payment from the issuer to facilitate the reporting person's ability to satisfy certain tax obligations related to the RSUs scheduled to vest."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The number of RSUs forfeited is based on a percentage."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 19, 2024, the reporting person was granted 8,207 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 19, 2024, the reporting person was granted 8,207 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024."}],"balance_after":6976,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1231},"source":{"system":"sec-edgar","filing":"0001104659-25-000367","document":"tm2432211-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925000367/tm2432211-2_4seq1.xml","form_type":"4"}},{"id":1318285,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-01-02T22:00:57.000Z","date":"2025-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":294,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The number of ordinary shares withheld to satisfy tax withholding obligations arising out the vesting of RSUs is based on a percentage and did not take into account any market value as the issuer's ordinary shares are not listed or quoted on a recognized trading market."}],"balance_after":1210,"source":{"system":"sec-edgar","filing":"0001104659-25-000367","document":"tm2432211-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925000367/tm2432211-2_4seq1.xml","form_type":"4"}},{"id":1318284,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-01-02T22:00:57.000Z","date":"2025-01-01","kind":"exercise","planned":false,"acquired":true,"shares":1504,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the issuer at one share per RSU."}],"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001104659-25-000367","document":"tm2432211-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925000367/tm2432211-2_4seq1.xml","form_type":"4"}},{"id":1474583,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-18T20:20:07.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 17, 2024 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service."}],"balance_after":30000,"derivative":{"exercise_price":7,"expiration_date":"2034-06-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-074884","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1617541/000095017024074884/ownership.xml","form_type":"4"}},{"id":1479103,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T20:20:07.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":47500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 12, 2025 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":47500,"derivative":{"exercise_price":8.88,"expiration_date":"2034-06-11","underlying":"Voting Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0000950170-24-073695","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017024073695/ownership.xml","form_type":"4"}},{"id":1632663,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-20T21:11:04.000Z","date":"2024-02-19","kind":"grant","planned":false,"acquired":false,"shares":8207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (the \"RSU\") will be settled in ordinary shares of the issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest ratably on each of the first three anniversaries of January 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest ratably on each of the first three anniversaries of January 1, 2024."}],"balance_after":8207,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8207},"source":{"system":"sec-edgar","filing":"0001104659-24-025519","document":"tm245307-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465924025519/tm245307-6_4seq1.xml","form_type":"4"}},{"id":1841796,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-29T20:16:51.000Z","date":"2023-06-27","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 27, 2023 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service."}],"balance_after":30000,"derivative":{"exercise_price":3.16,"expiration_date":"2033-06-26","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0000950170-23-030756","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1617541/000095017023030756/ownership.xml","form_type":"4"}},{"id":1854480,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T22:17:08.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 13, 2024 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":35000,"derivative":{"exercise_price":2.66,"expiration_date":"2033-06-12","underlying":"Voting Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-23-015642","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924323015642/doc4.xml","form_type":"4"}},{"id":2219170,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-29T21:00:36.000Z","date":"2022-06-27","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 27, 2022 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service."}],"balance_after":19000,"derivative":{"exercise_price":5.22,"expiration_date":"2032-06-26","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0000899243-22-024526","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1617541/000089924322024526/doc4.xml","form_type":"4"}},{"id":2244966,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-03T20:30:46.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":9146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 1, 2023 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":9146,"derivative":{"exercise_price":3.17,"expiration_date":"2032-05-31","underlying":"Voting Common Stock","underlying_shares":9146},"source":{"system":"sec-edgar","filing":"0000899243-22-020963","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924322020963/doc4.xml","form_type":"4"}},{"id":2285499,"issuer":{"id":127674,"kind":"organization","name":"US Ecology, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-03T16:29:29.000Z","date":"2022-05-02","kind":"disposition_to_issuer","acquired":false,"shares":3430,"price":48,"value":164640.0,"ownership":{"direct":false,"nature":"Retirement Account"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), entered into on February 8, 2022, by and among the Issuer, Republic Services, Inc. (\"Parent\") and Bronco Acquisition Corp. (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on February 10, 2022). At the effective time of the merger, each Issuer share of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $48.00 per share in cash without interest (\"Merger Consideration\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), entered into on February 8, 2022, by and among the Issuer, Republic Services, Inc. (\"Parent\") and Bronco Acquisition Corp. (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on February 10, 2022). At the effective time of the merger, each Issuer share of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $48.00 per share in cash without interest (\"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-22-010680","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783400/000143774922010680/rdgdoc.xml","form_type":"4"}},{"id":2285498,"issuer":{"id":127674,"kind":"organization","name":"US Ecology, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-03T16:29:29.000Z","date":"2022-05-02","kind":"disposition_to_issuer","acquired":false,"shares":10070,"price":48,"value":483360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), entered into on February 8, 2022, by and among the Issuer, Republic Services, Inc. (\"Parent\") and Bronco Acquisition Corp. (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on February 10, 2022). At the effective time of the merger, each Issuer share of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $48.00 per share in cash without interest (\"Merger Consideration\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), entered into on February 8, 2022, by and among the Issuer, Republic Services, Inc. (\"Parent\") and Bronco Acquisition Corp. (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on February 10, 2022). At the effective time of the merger, each Issuer share of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $48.00 per share in cash without interest (\"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-22-010680","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783400/000143774922010680/rdgdoc.xml","form_type":"4"}},{"id":2671301,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T21:10:24.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 9, 2021 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service."}],"balance_after":15000,"derivative":{"exercise_price":8.85,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-21-023282","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1617541/000089924321023282/doc4.xml","form_type":"4"}},{"id":2692283,"issuer":{"id":127674,"kind":"organization","name":"US Ecology, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-28T13:02:33.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":2900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock issued pursuant to US Ecology, Inc.'s director compensation program and the Amended and Restated US Ecology, Inc. Omnibus Incentive Plan."}],"balance_after":10070,"source":{"system":"sec-edgar","filing":"0001437749-21-013676","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783400/000143774921013676/rdgdoc.xml","form_type":"4"}},{"id":2764513,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-04-01T19:45:30.000Z","date":"2021-04-01","kind":"disposition_to_issuer","acquired":false,"shares":27994,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated February 24, 2021, among Pandion Therapeutics, Inc. (the \"Company\"), Merck Sharp & Dohme Corp. (\"Merck\") and Panama Merger Sub, Inc. (\"Merger Sub\"), Merger Sub commenced a tender offer (the \"Offer\") to purchase all outstanding Company common stock for the price of $60.00 per share in cash (the \"Offer Price\"). On April 1, 2021, the Offer consummated, after which Merger Sub merged with and into the Company (the \"Merger\") and the Company became a wholly owned subsidiary of Merck. At the consummation of the Offer and the Merger, respectively, (i) Merger Sub purchased all shares of Company common stock that were validly tendered pursuant to the Offer for a cash payment equal to the Offer Price and (ii) all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the \"Effective Time\"), were cancelled and converted automatically into the right to receive the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of pursuant to the Merger Agreement in exchange for the excess of the Offer Price over the exercise price of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All options were vested and exercisable as of immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":16.96,"expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":27994},"source":{"system":"sec-edgar","filing":"0000899243-21-014444","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807901/000089924321014444/doc4.xml","form_type":"4"}},{"id":2956735,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T20:04:06.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":27994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award was granted on December 2, 2020. The shares underlying the award vest in equal monthly installments following December 2, 2020 through December 2, 2023, subject to the reporting person's continued service on each applicable vesting date."}],"balance_after":27994,"derivative":{"exercise_price":16.96,"expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":27994},"source":{"system":"sec-edgar","filing":"0000899243-20-032796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807901/000089924320032796/doc4.xml","form_type":"4"}},{"id":3119540,"issuer":{"id":127674,"kind":"organization","name":"US Ecology, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-06-08T14:34:30.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":3100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock issued pursuant to US Ecology, Inc.'s director compensation program and Amended and Restated Omnibus Incentive Plan."}],"balance_after":7170,"source":{"system":"sec-edgar","filing":"0001437749-20-012603","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783400/000143774920012603/rdgdoc.xml","form_type":"4"}},{"id":3131358,"issuer":{"id":127674,"kind":"organization","name":"US Ecology, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-29T15:58:53.000Z","date":"2020-05-27","kind":"purchase","acquired":true,"shares":1100,"price":36.26,"value":39886.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were purchased by reporting person's retirement account."}],"balance_after":4070,"source":{"system":"sec-edgar","filing":"0001437749-20-012045","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783400/000143774920012045/rdgdoc.xml","form_type":"4"}},{"id":3131357,"issuer":{"id":127674,"kind":"organization","name":"US Ecology, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-29T15:58:53.000Z","date":"2020-05-27","kind":"sale","acquired":false,"shares":1100,"price":36.18,"value":39798.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price of 700 shares sold at $36.17 and 400 shares sold at $36.20."}],"balance_after":4070,"source":{"system":"sec-edgar","filing":"0001437749-20-012045","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783400/000143774920012045/rdgdoc.xml","form_type":"4"}},{"id":3317419,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-06T14:09:26.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":18571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 2, 2020 and is scheduled to vest in equal monthly installments through January 2, 2023, subject to continued service."}],"balance_after":18571,"derivative":{"exercise_price":15.86,"expiration_date":"2030-01-01","underlying":"Common Stock","underlying_shares":18571},"source":{"system":"sec-edgar","filing":"0000899243-20-000462","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1617541/000089924320000462/doc4.xml","form_type":"4"}},{"id":3384098,"issuer":{"id":127674,"kind":"organization","name":"US Ecology, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-01T12:35:09.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":2330,"ownership":{"direct":false,"nature":"Retirement Account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired pursuant to that certain Agreement and Plan of Merger, dated as of June 23, 2019, by and among US Ecology Holdings, Inc. (f/k/a US Ecology, Inc.) (\"Parent\"), NRC Group Holdings Corp., US Ecology, Inc. (f/k/a US Ecology Parent, Inc.) (\"Holdco\"), ECOL Merger Sub, Inc. (\"ECOL Merger Sub\") and Rooster Merger Sub, Inc., in a merger transaction in which ECOL Merger Sub merged with and into Parent, and each issued and outstanding share of Parent's common stock was converted into the right to receive, and became exchangeable for, one share of common stock, par value $0.01 of Holdco."}],"balance_after":2330,"source":{"system":"sec-edgar","filing":"0001437749-19-021232","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783400/000143774919021232/rdgdoc.xml","form_type":"4"}},{"id":3384097,"issuer":{"id":127674,"kind":"organization","name":"US Ecology, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-01T12:35:09.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":5170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired pursuant to that certain Agreement and Plan of Merger, dated as of June 23, 2019, by and among US Ecology Holdings, Inc. (f/k/a US Ecology, Inc.) (\"Parent\"), NRC Group Holdings Corp., US Ecology, Inc. (f/k/a US Ecology Parent, Inc.) (\"Holdco\"), ECOL Merger Sub, Inc. (\"ECOL Merger Sub\") and Rooster Merger Sub, Inc., in a merger transaction in which ECOL Merger Sub merged with and into Parent, and each issued and outstanding share of Parent's common stock was converted into the right to receive, and became exchangeable for, one share of common stock, par value $0.01 of Holdco."}],"balance_after":5170,"source":{"system":"sec-edgar","filing":"0001437749-19-021232","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783400/000143774919021232/rdgdoc.xml","form_type":"4"}},{"id":3384198,"issuer":{"id":154125,"kind":"organization","name":"US Ecology Holdings, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-01T09:38:47.000Z","date":"2019-11-01","kind":"disposition_to_issuer","acquired":false,"shares":2330,"ownership":{"direct":false,"nature":"Retirement Account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed pursuant to that certain Agreement and Plan of Merger, dated as of June 23, 2019, by and among US Ecology Holdings, Inc. (f/k/a US Ecology, Inc.) (\"Parent\"), NRC Group Holdings Corp., US Ecology, Inc. (f/k/a US Ecology Parent, Inc.) (\"Holdco\"), ECOL Merger Sub, Inc. (\"ECOL Merger Sub\") and Rooster Merger Sub, Inc., in a merger transaction in which ECOL Merger Sub merged with and into Parent, and each issued and outstanding share of Parent's common stock was converted into the right to receive, and became exchangeable for, one share of common stock, par value $0.01 of Holdco."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-19-021150","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/742126/000143774919021150/rdgdoc.xml","form_type":"4"}},{"id":3384197,"issuer":{"id":154125,"kind":"organization","name":"US Ecology Holdings, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-01T09:38:47.000Z","date":"2019-11-01","kind":"disposition_to_issuer","acquired":false,"shares":5170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed pursuant to that certain Agreement and Plan of Merger, dated as of June 23, 2019, by and among US Ecology Holdings, Inc. (f/k/a US Ecology, Inc.) (\"Parent\"), NRC Group Holdings Corp., US Ecology, Inc. (f/k/a US Ecology Parent, Inc.) (\"Holdco\"), ECOL Merger Sub, Inc. (\"ECOL Merger Sub\") and Rooster Merger Sub, Inc., in a merger transaction in which ECOL Merger Sub merged with and into Parent, and each issued and outstanding share of Parent's common stock was converted into the right to receive, and became exchangeable for, one share of common stock, par value $0.01 of Holdco."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-19-021150","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/742126/000143774919021150/rdgdoc.xml","form_type":"4"}},{"id":3514410,"issuer":{"id":154125,"kind":"organization","name":"US Ecology Holdings, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-23T15:48:31.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":1300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock issued pursuant to US Ecology, Inc.'s director compensation program and Omnibus Incentive Plan."}],"balance_after":5170,"source":{"system":"sec-edgar","filing":"0001437749-19-010743","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/742126/000143774919010743/rdgdoc.xml","form_type":"4"}},{"id":3793238,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-10T22:11:06.000Z","date":"2018-10-08","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vested on August 28, 2018, and the remaining 75% vest in equal monthly installments thereafter over a three-year period."}],"balance_after":148318,"derivative":{"exercise_price":0.91,"expiration_date":"2027-07-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-026516","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1617541/000089924318026516/doc4.xml","form_type":"4"}},{"id":3793237,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-10-10T22:11:06.000Z","date":"2018-10-08","kind":"exercise","acquired":true,"shares":10000,"price":0.91,"value":9100.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-18-026516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1617541/000089924318026516/doc4.xml","form_type":"4"}},{"id":3816586,"issuer":{"id":154125,"kind":"organization","name":"US Ecology Holdings, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-09-14T16:59:27.000Z","date":"2018-09-12","kind":"purchase","acquired":true,"shares":400,"price":74.55,"value":29820.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were purchased by the reporting person's retirement account."}],"balance_after":3870,"source":{"system":"sec-edgar","filing":"0001437749-18-017056","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/742126/000143774918017056/rdgdoc.xml","form_type":"4"}},{"id":3816585,"issuer":{"id":154125,"kind":"organization","name":"US Ecology Holdings, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-09-14T16:59:27.000Z","date":"2018-09-12","kind":"sale","acquired":false,"shares":1400,"price":74.55,"value":104370.0,"ownership":{"direct":true},"balance_after":3870,"source":{"system":"sec-edgar","filing":"0001437749-18-017056","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/742126/000143774918017056/rdgdoc.xml","form_type":"4"}},{"id":3917984,"issuer":{"id":154125,"kind":"organization","name":"US Ecology Holdings, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-25T16:16:46.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":1300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock issued pursuant to US Ecology, Inc.'s director compensation program and Omnibus Incentive Plan."}],"balance_after":5270,"source":{"system":"sec-edgar","filing":"0001437749-18-010741","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/742126/000143774918010741/rdgdoc.xml","form_type":"4"}},{"id":4225043,"issuer":{"id":154125,"kind":"organization","name":"US Ecology Holdings, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-08-25T17:49:18.000Z","date":"2017-08-25","kind":"purchase","acquired":true,"shares":600,"price":47.155,"value":28293.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were purchased by the reporting person's retirement account."}],"balance_after":3970,"source":{"system":"sec-edgar","filing":"0001437749-17-015348","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/742126/000143774917015348/rdgdoc.xml","form_type":"4"}},{"id":4225042,"issuer":{"id":154125,"kind":"organization","name":"US Ecology Holdings, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-08-25T17:49:18.000Z","date":"2017-08-25","kind":"sale","acquired":false,"shares":600,"price":47.145,"value":28287.0,"ownership":{"direct":true},"balance_after":3970,"source":{"system":"sec-edgar","filing":"0001437749-17-015348","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/742126/000143774917015348/rdgdoc.xml","form_type":"4"}},{"id":4305848,"issuer":{"id":154125,"kind":"organization","name":"US Ecology Holdings, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-25T17:18:35.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock issued pursuant to US Ecology, Inc.'s director compensation program and Omnibus Incentive Plan."}],"balance_after":4570,"source":{"system":"sec-edgar","filing":"0001437749-17-010109","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/742126/000143774917010109/rdgdoc.xml","form_type":"4"}},{"id":4603703,"issuer":{"id":154125,"kind":"organization","name":"US Ecology Holdings, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-09-14T09:55:09.000Z","date":"2016-09-12","kind":"purchase","acquired":true,"shares":1330,"price":44.3262,"value":58953.846,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were purchased by the reporting person's IRA."}],"balance_after":3070,"source":{"system":"sec-edgar","filing":"0001437749-16-038672","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/742126/000143774916038672/rdgdoc.xml","form_type":"4"}},{"id":4603702,"issuer":{"id":154125,"kind":"organization","name":"US Ecology Holdings, Inc.","symbol":"ECOL"},"owners":[{"id":29690,"kind":"person","name":"Dorton Katina","position":1,"cik":"0001617541","reported_name":"Dorton Katina","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-09-14T09:55:09.000Z","date":"2016-09-12","kind":"sale","acquired":false,"shares":1330,"price":44.3601,"value":58998.933,"ownership":{"direct":true},"balance_after":3070,"source":{"system":"sec-edgar","filing":"0001437749-16-038672","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/742126/000143774916038672/rdgdoc.xml","form_type":"4"}}]}